[1] World Health Organization. Human papillomavirus and cancer[EB/OL]. (2024-03-05)[2024-07-05]. https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer. [2] 王宇,宋淑芳,刘凤. 我国宫颈癌流行病学特征和发病高危因素的研究进展[J]. 中国妇幼保健,2019,34(5):1207-1209. [3] 艾海兵,陈亚楠,谷春会,等. 人乳头瘤病毒(HPV)相关性宫颈癌的研究进展[J]. 吉林医学,2017,38(1):169-171. [4] Yu L, Majerciak V, Zheng ZM.HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation[J]. Int J Mol Sci, 2022, 23(9): 4943. [5] Arbyn M, Weiderpass E, Bruni L, et al.Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis[J]. Lancet Glob Health, 2020, 8(2): e191-e203. [6] 施卫琴,沈磊芬,蔡丽文. 湖州市女性HPV感染及宫颈癌发生情况分析[J]. 实用预防医学,2021,28(5):621-624. [7] 谢珊艳,任鹏. 宫颈癌发病年轻化的趋势分析与相应对策[J]. 中医药管理杂志,2018,26(5):10-12. [8] 徐辉,张家祥,张澄,等. 我国子宫颈癌流行和防控研究进展[J]. 慢性病学杂志,2022(9):1360-1363,1368. [9] 杨金秀,阎岩,武志强. 2011—2020年郑州市二七区居民恶性肿瘤死亡趋势及减寿分析[J]. 实用预防医学,2022,29(7):769-773. [10] World Health Organization.Global strategy to accelerate the elimination of cervical cancer as a public health problem[R]. Geneva: World Health Organization, 2020. [11] World Health Organization.Strategic Advisory Group of Experts (SAGE) on immunization: Report of the SAGE Working Group on vaccine hesitancy[R]. Geneva: World Health Organization, 2014. [12] Wei Z, Liu Y, Zhang L, et al.Stages of HPV vaccine hesitancy among guardians of female secondary school students in China[J]. J Adolesc Health, 2023, 72(1): 73-79. [13] Macdonald NE.Vaccine hesitancy: Definition, scope and determinants[J]. Vaccine, 2015, 32(34): 4161-4164. [14] 魏征,傅传喜. 疫苗犹豫及其影响因素研究进展[J]. 微生物学免疫学进展,2019,47(5):74-78. [15] Betsch C, Bohm R, Chapman GB.Using behavioral insights to increase vaccination policy effectiveness[J]. Policy Insights Behav Brain Sci, 2015, 2(1): 61-73. [16] Nath R, Ratul A, Nath SD, et al.Role of vaccine hesitancy, eHealth literacy, and vaccine literacy in young adults' COVID-19 vaccine uptake intention in a lower-middle-income country[J]. Vaccines, 2021, 9(12): 1405. [17] 宋祎凡,叶家楷,曾淇民,等. 我国儿童监护人免疫规划疫苗犹豫现状及影响因素分析[J]. 中国预防医学杂志,2023,24(12):1303-1308. [18] An J, Liu Y, Ma Y, et al.Real-world data of China:Analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese Provinces from 2018 to 2021[J]. Hum Vaccin Immunother, 2024, 20(1): 2315653. [19] 仲志磊,陈秋语,马瑞岚,等. 关于新型冠状病毒肺炎疫情背景下疫苗犹豫应对的思考[J]. 药物不良反应杂志,2021,23(7):337-341. [20] 搜狐. 约苗发布《女性HPV预防认知洞察报告》[EB/OL]. (2022-08-31)[2024-07-05]. https://www.sohu.com/a/581419043_120181749. [21] 吴华梅,陈星,邹海燕,等. 2022年上海市高校女生HPV疫苗犹豫及影响因素研究[J]. 实用预防医学,2023,30(9):1055-1059. [22] Wang W, Ma Y, Wang X, et al.Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China[J]. Vaccine, 2015, 33(22): 2570-2576. [23] 熊黎黎,吴英弘,谢冬华,等. 湖南省适龄农村妇女对宫颈癌筛查项目的认知状况及影响因素分析[J]. 实用预防医学,2024,31(2):143-147. [24] Yang Y, Minglei X, Jiandong S, et al.Human papillomavirus infection and vaccination: Awareness and knowledge of HPV and acceptability of HPV vaccine among mothers of teenage daughters in Weihai, Shandong, China[J]. PLoS One, 2016, 11(1): e0146741. [25] 吴志芳,钱晓华,胡家瑜. 某镇小学女生母亲对人乳头瘤病毒及其疫苗认知调查[J]. 健康教育与健康促进,2021,16(6):577-581. [26] Falcaro M, Castaon A, Ndlela B, et al.The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study[J]. Lancet, 2021, 398(10316): 2084-2092. |